These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

707 related items for PubMed ID: 20206480

  • 1. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections.
    Desbois AP, Gemmell CG, Coote PJ.
    Int J Antimicrob Agents; 2010 Jun; 35(6):559-65. PubMed ID: 20206480
    [Abstract] [Full Text] [Related]

  • 2. Surface disinfection properties of the combination of an antimicrobial peptide, ranalexin, with an endopeptidase, lysostaphin, against methicillin-resistant Staphylococcus aureus (MRSA).
    Desbois AP, Lang S, Gemmell CG, Coote PJ.
    J Appl Microbiol; 2010 Feb; 108(2):723-30. PubMed ID: 19709343
    [Abstract] [Full Text] [Related]

  • 3. Potent, synergistic inhibition of Staphylococcus aureus upon exposure to a combination of the endopeptidase lysostaphin and the cationic peptide ranalexin.
    Graham S, Coote PJ.
    J Antimicrob Chemother; 2007 Apr; 59(4):759-62. PubMed ID: 17324959
    [Abstract] [Full Text] [Related]

  • 4. MRSA decolonization of cotton rat nares by a combination treatment comprising lysostaphin and the antimicrobial peptide ranalexin.
    Desbois AP, Sattar A, Graham S, Warn PA, Coote PJ.
    J Antimicrob Chemother; 2013 Nov; 68(11):2569-75. PubMed ID: 23800902
    [Abstract] [Full Text] [Related]

  • 5. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit.
    Dajcs JJ, Hume EB, Moreau JM, Caballero AR, Cannon BM, O'Callaghan RJ.
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1432-7. PubMed ID: 10798659
    [Abstract] [Full Text] [Related]

  • 6. Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model.
    Kokai-Kun JF, Chanturiya T, Mond JJ.
    J Antimicrob Chemother; 2007 Nov; 60(5):1051-9. PubMed ID: 17848374
    [Abstract] [Full Text] [Related]

  • 7. Treatment of methicillin-resistant Staphylococcus aureus in neonatal mice: lysostaphin versus vancomycin.
    Placencia FX, Kong L, Weisman LE.
    Pediatr Res; 2009 Apr; 65(4):420-4. PubMed ID: 19127212
    [Abstract] [Full Text] [Related]

  • 8. Lysostaphin: an antistaphylococcal agent.
    Kumar JK.
    Appl Microbiol Biotechnol; 2008 Sep; 80(4):555-61. PubMed ID: 18607587
    [Abstract] [Full Text] [Related]

  • 9. [Topical use of lysostaphin for Staphylococcus aureus infection of burn wounds in mice].
    Huan JN.
    Zhonghua Wai Ke Za Zhi; 1992 May; 30(5):270-1, 316. PubMed ID: 1289000
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Development of chitosan-collagen hydrogel incorporated with lysostaphin (CCHL) burn dressing with anti-methicillin-resistant Staphylococcus aureus and promotion wound healing properties.
    Cui F, Li G, Huang J, Zhang J, Lu M, Lu W, Huan J, Huang Q.
    Drug Deliv; 2011 Apr; 18(3):173-80. PubMed ID: 20726806
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The bactericidal effect of lysostaphin coupled with liposomal vancomycin as a dual combating system applied directly on methicillin-resistant Staphylococcus aureus infected skin wounds in mice.
    Hajiahmadi F, Alikhani MY, Shariatifar H, Arabestani MR, Ahmadvand D.
    Int J Nanomedicine; 2019 Apr; 14():5943-5955. PubMed ID: 31447553
    [Abstract] [Full Text] [Related]

  • 14. [Methicillin-resistant Staphylococcus aureus infection and its treatment in burned patients].
    Huan JN, Chen YL, Ge SD.
    Zhonghua Wai Ke Za Zhi; 1994 Apr; 32(4):244-5. PubMed ID: 7842932
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of dalbavancin, tigecycline, minocycline, tetracycline, teicoplanin and vancomycin against community-associated and multidrug-resistant hospital-associated meticillin-resistant Staphylococcus aureus.
    Huang V, Cheung CM, Kaatz GW, Rybak MJ.
    Int J Antimicrob Agents; 2010 Jan; 35(1):25-9. PubMed ID: 19900792
    [Abstract] [Full Text] [Related]

  • 17. Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice.
    Kokai-Kun JF, Chanturiya T, Mond JJ.
    J Antimicrob Chemother; 2009 Jul; 64(1):94-100. PubMed ID: 19398455
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis.
    Lefebvre M, Jacqueline C, Amador G, Le Mabecque V, Miegeville A, Potel G, Caillon J, Asseray N.
    Int J Antimicrob Agents; 2010 Dec; 36(6):542-4. PubMed ID: 20851576
    [Abstract] [Full Text] [Related]

  • 19. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
    Rose WE, Poppens PT.
    J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of linezolid against Panton-Valentine leukocidin (PVL)-positive meticillin-resistant Staphylococcus aureus (MRSA) in a mouse model of haematogenous pulmonary infection.
    Yanagihara K, Kihara R, Araki N, Morinaga Y, Seki M, Izumikawa K, Kakeya H, Yamamoto Y, Yamada Y, Kohno S, Tsukamoto K, Kamihira S.
    Int J Antimicrob Agents; 2009 Nov; 34(5):477-81. PubMed ID: 19665359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.